Published: 2020-04-27

Use of del nido cardioplegia versus St. thomas solution 2 in adult mitral valve replacement surgery at a tertiary care hospital in Kolkata, India

Swarnendu Datta, Ushnish Chakrabarty, Tanmoy Podder, Plaban Mukherjee


Background: del Nido cardioplegia has been historically used in paediatric cardiac surgery. However it’s use in adults has also been documented. It has the advantage of 90 minutes of cardiac inactivity over St. Thomas solution no.-2, which requires repeated dosing at 20 minutes interval. Aim of this study to find out whether del Nido cardioplegia with longer duration of arrest is advantageous over St. Thomas solution no. 2 in adult mitral valve replacement.

Methods: Total 60 patients of severe mixed mitral valve disease of comparable patient profiles, underwent mitral valve replacement with preservation of anterolateral and posteromedial chordae. Half the patients received del Nido cardioplegia and other half received St. Thomas solution no 2. (ST-2). The two groups were compared.

Results: del Nido group had lesser CPB time (70.73±12.15min) as compared to ST-2 group (81.76±20.03min) with  p=0.01 ; lesser Cross clamp time (del Nido- 68.8±10.64min; ST-2- 75.83±14.00min) with p=0.02; lesser time taken to arrest heart  (del Nido- 21.58±13.37 sec; ST-2- 25.26±5.27 sec) with p=0.04 & lesser time taken for normal ECG activity to manifest after release of cross clamp (del Nido- 19.86±6.10 min; ST-2- 31.03±5.28min) with p=0.02. All other parameters did not reach statistical significance.

Conclusions: del Nido cardioplegia group of patients required significantly less CPB time; Cross-clamp time; Mean time taken to arrest the heart; as well as that taken to manifest normal ECG morphology when compared to ST-2 group.


del Nido, Mitral, St. Thomas

Full Text:



Yamamoto H, Yamamoto F. Myocardial protection in cardiac surgery: A historical review from the beginning to current topics. Gen Thoracic Surg. 2013;61(9):485-96.

Lopez JR, Jahangir R, Jahangir A, Shen WK, Terzic A. Potassium channel openers prevent potassium-induced calcium loading of cardiaccells: Possible implications in cardioplegia. J Thorac Cardiovasc Surg. 1996;112(3):820-31.

Cyran SE, Ditty SE, Baylen BG, Cheung J, LaNoue KF. Developmental differences in the response of cytosolic free calcium to potassium depolarization and cardioplegia in cardiac myocytes. J Mol Cell Cardiol. 1992;24(10):1167-77.

Dobson GP, Jones MW. Adenosine and lidocaine: A new concept in non-depolarising surgical myocardial arrest, protection and preservation. J Thorac Cardiovasc Surg. 2004;127(3):794-805

Hearse DJ, Stewart DA, Braimbridge MV. Myocardial protection during ischemia cardiac arrest: The importance of magnesium in cardioplegic infusates. J Thorac Cardiovasc Surg. 1978;75(6):877-85.

Shiroishi M. Myocardial protection. The rebirth of potassium-basedcardioplegia. Tex Heart Inst J. 1999;26(1):71-86.

Gravlee P, Davis R, Stammers A, Ungerleider R. CardiopulmonaryBypass: Principles and Practice. Philadelphia, PA: William & Wilkins; 2008.

Matte GS, del Nido PJ. History and use of del Nido cardioplegia solution atBoston Children’s Hospital. JECT 2012;44(3):98-103.

Mick SL, Robich MP, Houghtaling PL, Gillinov AM, Soltesz EG, Johnston DR, Blackstone EH, Sabik JF 3rd. Del Nido versus Buckberg cardioplegia in adult isolated valve surgery. J Thorac Cardiovasc Surg. 2015;149(2):626-34.

Smigla G, Jaquiss R, Walczak R, Bonadonna D, Kaemmer D, Schwimer C, Lodge A. Assessing the safety of del Nido cardioplegia solution in adult congenital cases. Perfusion. 2014;29(6):554-8.

Garcia-Dorado D, Ruiz-Meana M, Inserte J, Rodriguez-Sinovas A, Piper HM. Calcium-mediated cell death during myocardial reperfusion. Cardiovascular research. 2012 May 1;94(2):168-80.

O’Brien JD, Howlett SE, Burton HJ, O’Blenes SB, Litz DS, Friesen CL. Pediatric cardioplegia strategy results in enhanced calcium metabolism and lower serum troponin T. Ann Thorac Surg. 2009 May 1;87(5):1517-23.